Incorporating high-sensitivity cardiac troponin assays into clinical practice: These assays are your friend

Heart and Metabolism

Volumn , Issue 67, 2015, Pages 9-14

  Love, Sara ^a   Sandoval, Yader ^a   Apple, Fred S ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Biomarkers; Cardiac troponin; Diagnostic accuracy; High sensitivity assays; Myocardial infarction; Outcomes

Indexed keywords

TROPONIN;

ACUTE CORONARY SYNDROME; ARTICLE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL ASSESSMENT; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EVIDENCE BASED PRACTICE; HEART MUSCLE ISCHEMIA; HIGH SENSITIVITY CARDIAC TROPONIN ASSAY; HUMAN; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SECONDARY PREVENTION;

EID: 84938944007     PISSN: 15660338     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012;20:2551-2567.
2. Apple FS, Collinson PO; IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Analytical characteristics of highsensitivity cardiac troponin assays. Clin Chem. 2011;58:54-61.
3. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem. 2012;58:1574-1581.
4. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) website. Working group on standardization of troponin I: http://www.ifcc.org/ifcc-scientific-division/sd-working-groups/wg-tni/. Accessed April 10, 2015.
5. Newby LK, Jesse RL, Babb JD, et al. ACCF 2012 Expert Consensus Document on Practical Clinical Considerations in the Interpretation of Troponin Elevations: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2012;60:2427-2463.
6. McKie PM, Heublein DM, Scott CG, et al. Defining high-sensitivity cardiac troponin concentrations in the community. Clin Chem. 2013;59:1099-1107.
7. Shah A, Griffiths M, Lee KK, et al. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women. BMJ. 2015;350:g7873. doi:10.1136/bmj.g7873.
8. Sandoval Y, Apple FS. The global need to define normality: the 99th percentile value of cardiac troponin. Clin Chem. 2013; 60:455-462.
9. Thygesen K, Mair J, Giannitsis E, et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J. 2012;33:2252-2257.
10. Jaffe AS, Moeckel M, Giannitsis E, et al. In search for the Holy Grail: suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: a position paper from the study group on biomarkers of the Acute Cardiovascular Care Association. Eur Heart J Acute Cardiovasc Care. 2014;3:313-316.
11. Sandoval Y, Smith SW, Schulz K, et al. Diagnosis of type 1 and type 2 myocardial infarction using a high-sensitivity cardiac troponin I assay with gender-specific 99th percentiles based on the Third Universal Definition of myocardial infarction classification system. Clin Chem. 2015;61:657-663.
12. Markam AN, Nguyen OK. Use of cardiac biomarker testing in the Emergency Department. JAMA Intern Med. 2015;175:67-75.
13. Brunel V, Larson T, Peschanski N, et al. Evaluation of hemolysis in emergency department samples requesting high sensitivity troponin T measurement. Ann Clin Biochem. 2012;5:509-510.
14. Keller T, Zeller T, Ojeda F, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA. 2011;306:2684-2693.
15. Reichlin T, Irfan A, Twerenbold R, et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation. 2011;124:136-145.
16. Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem. 2009;55:1303-1306.
17. Reichlin T, Schindler C, Drexler B, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med. 2012;172:1211-1218.
18. Body R, Carley S, McDowell G, et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol. 2011;58:1332-1339.
19. Bandstein N, Ljung R, Johansson M, Holzmann MJ. Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction. J Am Coll Cardiol. 2014;63:2569-2578.
20. Cullen L, Mueller C, Parsonage WA, et al. Validation of highsensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol. 2013;62:1242-1249.
21. Reichlin T, Twerenbold R, Reiter M, et al. Introduction of highsensitivity troponin assays: impact on myocardial infarction incidence and prognosis. Am J Med. 2012;125:1205-1213.
22. Sandoval Y, Smith SW, Thordsen SE, Apple FS. Supply/demand type 2 myocardial infarction: should we be paying more attention? J Am Coll Cardiol. 2014;63:2079-2087.
23. Alpert JS, Thygesen KA, White HD, Jaffe AS. Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. Am J Med. 2014;127:105-108.
24. Morrow DA, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry practice guidelines: clinical characteristics and utilization of biomarkers in acute coronary syndromes. Clin Chem. 2007;53:552-574.
25. Sabatine MS, Morrow DA, de Lemos JA. Jarolim P, Braunwald E. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischemia using an ultrasensitive assay: results from the TIMI 25. Eur Heart J. 2009;30:162-169.
26. Omland T, de Lemos JA, Sabatine MS, et al. A sensitive cardiac troponin T assay in stable coronary disease. N Engl J Med. 2009;361:2538-2547.
27. Irfan A, Twerenbold R, Reiter M, et al. Determinants of highsensitivity troponin T among patients with a noncardiac cause of chest pain. Am J Med. 2012;125:491-498.
28. de Filippi CR, de Lemos JA, Christenson RH, et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA. 2010;304:2494-2502.
29. de Lemos JA, Drazner MH, Omland T, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA. 2010;304:2503-2512.
30. Apple FS, Steffen LM, Pearce LA, Murakami MM, Luepker RV Increased cardiac troponin I as measured by a high-sensitivity assay Is associated with high odds of cardiovascular death: the Minnesota Heart Survey. Clin Chem. 2012;58:930-935.
31. Korley FK, Jaffe AS. Preparing the United States for highsensitivity cardiac troponin assays. J Am Coll Cardiol. 2013;61:1753-1758.
32. Kavsak PA, Allen LC, Apple FS, et al. Cardiac troponin testing in the acute care setting: ordering, reporting, and high sensitivity assays - an update from the Canadian Society of Clinical Chemists (CSCC). Clin Biochem. 2011;44:1273-1277.